Serologic testing for human immunodeficiency virus antibodies (Q45833646)

16 December 2017

title

Serologic testing for human immunodeficiency virus antibodies (English)

1 reference

16 December 2017

1 reference

J M Steckelberg

1

1 reference

16 December 2017

F R Cockerill

series ordinal

2

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 April 1988

1 reference

16 December 2017

published in

Mayo Clin Proc

1 reference

16 December 2017

volume

63

1 reference

16 December 2017

issue

4

1 reference

16 December 2017

page(s)

373-380

1 reference

16 December 2017

Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Testing for human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

A Pathogenic Retrovirus (HTLV-III) Linked to AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

HTLV-III in symptom-free seronegative persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Envelope gene-derived recombinant peptide in the serodiagnosis of human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide. Comparison to Western blot on 2707 consecutive serum samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Serological characterization of HTLV-III infection in AIDS and related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Predictive value of a screening test for antibodies to HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Which anti-HTLV III/LAV assays for screening and confirmatory testing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Seroimmunology of AIDS retrovirus infection. I. Use of immunofluorescence assay to confirm sera with ELISA reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

False-positive Western blot tests for antibodies to HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Primary human T-lymphotropic virus type III infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

HTLV-III infection associated with glandular-fever-like illness in a haemophiliac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Acute encephalopathy coincident with seroconversion for anti-HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Antibody response to human immunodeficiency virus after primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964860-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)64860-5

1 reference

16 December 2017

1 reference

16 December 2017